Zoetis | ZTS - Operating Expenses

Stock Price
122.41
Daily Change
-2.53 -2.03%
Monthly
-5.38%
Yearly
-28.93%
Q1 Forecast
120.98

Zoetis reported $5.4B in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
AbbVie USD -2.64B 12.35B Sep/2025
Align Technology USD 811.05M 38.37M Sep/2025
Bayer EUR 10.2B 523M Sep/2025
Bristol-Myers Squibb USD 18.55B 10.06B Sep/2025
Charles River Laboratories USD 3.41B 2.51B Sep/2025
Dentsply International USD 1.48B 653M Sep/2025
Eli Lilly USD 9.21B 677.8M Sep/2025
Henry Schein USD 3.14B 77M Sep/2025
Idexx Laboratories USD 774.97M 24.58M Dec/2025
Illumina USD 834M 20M Sep/2025
IQVIA Holdings USD 6.16B 2.7B Sep/2025
J&J USD 18.97B 2.38B Dec/2025
Laboratory Of America USD 3.17B 101.7M Sep/2025
Merck USD 10.72B 1.28B Sep/2025
Neogen USD 230.07M 4.79M Sep/2025
Pacira USD 166.36M 4.5M Sep/2025
Perrigo USD 949.9M 50.8M Sep/2025
Pfizer USD 92.8B 82.47B Sep/2025
Quest Diagnostics USD 7.26B 4.94B Sep/2025
Sanofi EUR 10.51B 1.21B Dec/2025
Sanofi EUR 10.71B 1.32B Dec/2025
Zoetis USD 5.4B 3.94B Sep/2025